• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC IRELAND VALIANT NAVION; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC IRELAND VALIANT NAVION; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TR Back to Search Results
Model Number VNMF4040C223TE
Device Problem Migration or Expulsion of Device (1395)
Patient Problem Ulcer (2274)
Event Date 07/20/2021
Event Type  Injury  
Manufacturer Narrative
Medtronic received the following information obtained from the journal article entitled; penetrating aortic ulcer post migration of thoracic aortic endoprosthesis: case report dinoto et al, international journal of surgery case reports, volume 85, 2021, https://doi.Org/10.1016/j.Ijscr.2021.106219.Implant date: unknown.If information is provided in the future, a supplemental report will be issued.
 
Event Description
A valiant navion (40 × 223mm) stent graft system was implanted in a patient during an emergent endovascular procedure for type b aortic dissection (tbad) complicated by symptomatic large infrarenal aaa.Chimney technique was performed for the left subclavian artery and petticoat with evar (endurant ii 32mm stent graft).It was reported that the 12 month follow up ct showed a pau on the little curve of the aortic arch with migration of the prosthesis.Follow up at 15 months showed an increase of pau with partial crush of stent in lsa without significative change of flow in left arm.To prevent further deterioration of the aortic lesion, a secondary procedure was completed.2 non mdt (38 × 150 mm and 42 × 100 mm) stents were placed and deployed in zone 2 of the aortic arch in front of the proximal end of the navion graft.The control angiography confirmed the adequate proximal sealing and the absence of leakages with lsa patency.The procedure was completed with no further complications reported and the patient discharged after 7 days.Per the physician the cause of the pau was possibly due to migration of the endoprosthesis and fragility of the aortic wall.No additional clinical sequelae were reported and the patient is fine.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VALIANT NAVION
Type of Device
SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TR
Manufacturer (Section D)
MEDTRONIC IRELAND
parkmore business park west
galway
EI 
Manufacturer (Section G)
MEDTRONIC IRELAND
parkmore business park west
galway
EI  
Manufacturer Contact
alison sweeney
parkmore business park west
galway 
EI  
091708096
MDR Report Key12670981
MDR Text Key277624429
Report Number9612164-2021-04039
Device Sequence Number1
Product Code MIH
Combination Product (y/n)N
Reporter Country CodeIT
PMA/PMN Number
P100040
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Physician
Type of Report Initial
Report Date 10/21/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberVNMF4040C223TE
Device Catalogue NumberVNMF4040C223TE
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 10/15/2021
Initial Date FDA Received10/21/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age67 YR
-
-